A gel injection may erase 'tech neck' lines, and a trial puts it to the test
NCT ID NCT05316233
First seen Sep 03, 2026 · Last updated Sep 04, 2026 · Updated 1 time
Summary
This Phase 3 trial tests whether JUVÉDERM VOLITE XC, a hyaluronic acid gel with lidocaine, can safely reduce horizontal neck lines and improve skin smoothness in adults. Participants with moderate to severe neck lines are randomly assigned to receive the gel or no treatment, with follow-up over several months. Researchers measure improvement using a standard scale and track side effects.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- JUVÉDERM VOLITE XC, a hyaluronic acid gel with lidocaine, injected into the neck
- What this could lead to
- If it works, this could offer a minimally invasive option for smoothing horizontal neck lines and improving skin texture.
- What could go wrong
- The trial is still testing safety and effectiveness, and results may not hold for everyone. Injections carry risks like swelling, bruising, or infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
159 people
The number who actually took part.
- Started
-
May 2022
- Finished
-
Sep 2024
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
22 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Participants in general good health as determined by Treating Investigator's judgment, including no known active pandemic infection. * Participants seeking improvement of transverse neck lines. * Has moderate or severe transverse neck lines (ATNLS Grade 2 or 3) based on EI live assessment. Exclusion Criteria: * Neck deformity or significant skin laxity with severe redundant folds. * Significant skin pigmentation disorders or discoloration in the neck area that would interfere with the visual assessment of the neck area. * Current cutaneous inflammatory or infectious processes (eg. acne, herpes), abscess, an unhealed wound, or a cancerous or precancerous lesion on the neck. * Tendency to develop hypertrophic scarring. * History of thyroid cancer, skin cancer of the neck, radiation of the treatment area, or de novo cancer in the treatment area. * Permanent soft tissue fillers in the neck area. * Semi-permanent soft tissue fillers in the neck area within 2 years before enrollment. * HA fillers or autologous fat in the neck area within 12 months before enrollment. * Mesotherapy, photomodulation, intense pulsed light, radiofrequency, dermabrasion, chemical peel, microneedling, laser, or other cosmetic procedures in the neck area within 12 months before enrollment. * Botulinum toxin in the neck area within 6 months before enrollment. * Deoxycholic acid injections or cryolipolysis in the submentum area within 6 months before enrollment. * Neck surgeries and procedures. * Neck tattoos, piercings, pigmentation, hair, or past trauma that would interfere with the visualization of the neck area for the effectiveness assessments. * Pregnant, nursing or planning a pregnancy.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Neck lines are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aesthetic Solutions /ID# 239074
Chapel Hill, North Carolina, 27517-9901, United States
-
Art of Skin MD /ID# 239071
Solana Beach, California, 92075-2228, United States
-
Bellaire Dermatology Associates /ID# 239133
Bellaire, Texas, 77401, United States
-
Center for Dermatology and Dermatologic Surgery /ID# 239137
Washington D.C., District of Columbia, 20037-1445, United States
-
Cosmetic Laser Dermatology /ID# 239121
San Diego, California, 92121-2119, United States
-
Delricht Research /ID# 242001
New Orleans, Louisiana, 70115, United States
-
Hevia Cosmetic Dermatology /ID# 239118
Coral Gables, Florida, 33134, United States
-
Laser & Skin surgery Medical group, Inc /ID# 241999
Sacramento, California, 95816-5520, United States
-
Mariwalla Dermatology /ID# 239102
West Islip, New York, 11795-4916, United States
-
Research Institute of the Southeast, LLC /ID# 239070
West Palm Beach, Florida, 33401-2712, United States
-
Rkmd, Llc /Id# 239075
North Bethesda, Maryland, 20852-3093, United States
-
Skin And Aesthetics Surgery Of Manhattan /ID# 243607
New York, New York, 10022-3607, United States
-
Skin Research Institute LLC /ID# 239109
Coral Gables, Florida, 33146-1837, United States
-
Steve Yoelin MD Medical Associate Inc /ID# 239072
Newport Beach, California, 92663, United States
-
image Dermatology, P.C. /ID# 239136
Montclair, New Jersey, 07042, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.